We are excited to announce Venable’s inaugural Life Sciences Webinar Series. This month-long series will explore the intricacies and latest developments that shape the life sciences industry. Join us as we hear from our...more
10/3/2023
/ Abbreviated New Drug Application (ANDA) ,
Hatch-Waxman ,
Inducement ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
IP Portfolio ,
Life Sciences ,
Noninfringement ,
Obviousness-Type Double Patenting (ODP) ,
OTDP ,
Patent Applications ,
Patent Infringement ,
Patent Term Adjustment ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Section 112 ,
Webinars ,
Written Descriptions